Stockreport

AngioDynamics launches long-term study of NanoKnife for prostate cancer [Yahoo! Finance]

AngioDynamics, Inc.  (ANGO) 
Last angiodynamics, inc. earnings: 4/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.angiodynamics.com/investor-relations
PDF long-term effects of the NanoKnife system for treating unifocal intermediate-risk prostate cancer. The system uses irreversible electroporation (IRE) technology to tre [Read more]